News – Page 1029 – Endpoints News

A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

7 years ago

Vant commander Ramaswamy heads back to Nasdaq with a $150M pitch — are investors ready to forgive Axovant?

7 years ago

Taiho kicks off $130M Arcus deal with drug option; J&J allies with Merck KGaA to take diabetes drug to China

7 years ago

George Golumbeski's first stop out of Celgene: Grail; Roivant taps Genentech vet Myrtle Potter for operations role

7 years ago

After long delay following patient death, FDA lifts trial hold on Advaxis/AstraZeneca combo

7 years ago

Senate Dems blast Novartis’ ties to Trump attorney, claim pharma giant offered misleading explanations in damning ...

7 years ago

Biogen vet George Scangos jumps on the board at upstart MS case manager Octave, backed by Section 32

7 years ago

Amgen, UCB are back pitching once-rejected osteoporosis drug romo to the FDA — but big hurdles lie ahead

7 years ago

Investigative report calls for renewed scrutiny on Acadia drug; Imbruvica fails in frontline DLBCL PhIII

7 years ago

On the heels of GW's epilepsy win, Wall Street darling Zogenix shares positive PhIII data on rival drug

7 years ago

Hoping to shake Allergan/Shire's dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug

7 years ago

FDA lays down the law on gene therapy, offering guidances on both diseases and procedures

7 years ago

Ramaswamy’s Dermavant bags GSK’s PhIII-ready psoriasis drug in $330M deal — eyeing a major league contest

7 years ago

Parker Institute scientists herald a cell therapy breakthrough in the lab, using next-gen CRISPR tech to engineer T ...

7 years ago

Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more

7 years ago

VC money booms in Q2, with mega-deals hitting record levels

7 years ago

Thiel-backed Compass adds $49M to A round, bringing total to $132M

7 years ago

Senator Wyden prods Trump/Pfizer for details, calling drug pricing stunt 'long on theatrics, short on relief'

7 years ago

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

7 years ago

Bristol-Myers Squibb's Opdivo/Yervoy combo scores colorectal cancer OK; Former Akebia, Merrimack staffers found ...

7 years ago

Pfizer reshuffles, splitting into three business units

7 years ago

12 top China VCs you need to know who are making a transpacific splash (Part 2)

7 years ago

Novartis punts a late-stage PI3K drug with a worrying safety profile to one of China’s upstart biotechs

7 years ago

Otsuka jumps into the US biotech M&A game, bagging Visterra in $430M buyout

7 years ago

First page Previous page 1026 1027 102810291030 1031 1032 Next page Last page